International audienceNonlinear mixed effects models (NLMEM) are used in pharmacokinetics to analyse concentrations of patients during drug development, particularly for pediatric studies. Approaches based on the Fisher information matrix can be used to optimize their design. Local design needs some a priori parameter values which might be difficult to guess. Therefore two-stage adaptive designs are useful to provide some flexibility. We implemented in the R function PFIM the Fisher matrix for two-stage designs in NLMEM. We evaluated, with simulations, the impact of one-stage and two-stage designs on the precision of parameter estimation when the true and a priori parameters are different
International audienceWe focus on the Fisher information matrix used for design evaluation and optim...
International audiencePurpose: In this study we aimed to evaluate adaptive designs (ADs) by clinical...
International audiencePurpose: In this study we aimed to evaluate adaptive designs (ADs) by clinical...
International audienceNonlinear mixed effects models (NLMEM) are used in pharmacokinetics to analyse...
International audienceNonlinear mixed effects models (NLMEM) are used in pharmacokinetics to analyse...
International audienceNonlinear mixed effects models (NLMEM) are used in pharmacokinetics to analyse...
International audienceNonlinear mixed effects models (NLMEM) are used in pharmacokinetics to analyse...
International audienceNonlinear mixed effects models (NLMEM) are used in pharmacokinetics to analyse...
International audienceNonlinear mixed-effect models are used increasingly during drug development. F...
International audiencePurpose: In this study we aimed to evaluate adaptive designs (ADs) by clinical...
International audiencePurpose: In this study we aimed to evaluate adaptive designs (ADs) by clinical...
International audienceBackground and objective: Nonlinear mixed-effect models (NLMEMs) are increasin...
International audienceBackground and objective: Nonlinear mixed-effect models (NLMEMs) are increasin...
International audienceBackground and objective: Nonlinear mixed-effect models (NLMEMs) are increasin...
International audienceBackground and objective: Nonlinear mixed-effect models (NLMEMs) are increasin...
International audienceWe focus on the Fisher information matrix used for design evaluation and optim...
International audiencePurpose: In this study we aimed to evaluate adaptive designs (ADs) by clinical...
International audiencePurpose: In this study we aimed to evaluate adaptive designs (ADs) by clinical...
International audienceNonlinear mixed effects models (NLMEM) are used in pharmacokinetics to analyse...
International audienceNonlinear mixed effects models (NLMEM) are used in pharmacokinetics to analyse...
International audienceNonlinear mixed effects models (NLMEM) are used in pharmacokinetics to analyse...
International audienceNonlinear mixed effects models (NLMEM) are used in pharmacokinetics to analyse...
International audienceNonlinear mixed effects models (NLMEM) are used in pharmacokinetics to analyse...
International audienceNonlinear mixed-effect models are used increasingly during drug development. F...
International audiencePurpose: In this study we aimed to evaluate adaptive designs (ADs) by clinical...
International audiencePurpose: In this study we aimed to evaluate adaptive designs (ADs) by clinical...
International audienceBackground and objective: Nonlinear mixed-effect models (NLMEMs) are increasin...
International audienceBackground and objective: Nonlinear mixed-effect models (NLMEMs) are increasin...
International audienceBackground and objective: Nonlinear mixed-effect models (NLMEMs) are increasin...
International audienceBackground and objective: Nonlinear mixed-effect models (NLMEMs) are increasin...
International audienceWe focus on the Fisher information matrix used for design evaluation and optim...
International audiencePurpose: In this study we aimed to evaluate adaptive designs (ADs) by clinical...
International audiencePurpose: In this study we aimed to evaluate adaptive designs (ADs) by clinical...